Modulators for amyloid beta

Details for Australian Patent Application No. 2009301210 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Goetschi, Erwin; Jolidon, Synese; Luebbers, Thomas

Agent Spruson & Ferguson

Pub. Number AU-A-2009301210

PCT Pub. Number WO2010/040661

Priority 08166228.0 09.10.08 EP

Filing date 29 September 2009

Wipo publication date 15 April 2010

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/040661 Priority application(s): WO2010/040661

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009301211-Method of cigarette packaging and cigarette packaging system

2009301209-Pseudoproline dipeptides